Hashem Shahroosvand | Anticancer and Immunologist | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Dr. Hashem Shahroosvand | Anticancer and Immunologist | Best Researcher Award

University of Zanjan | Iran

Prof. Hashem Shahroosvand is an accomplished researcher in organic electronics, solar energy materials, and advanced photonic systems, recognised for influential contributions to dye-sensitized and perovskite solar cell technology as well as light-emitting electrochemical devices. He holds strong academic foundations through advanced training and qualifications in chemistry and materials science, complemented by progressive academic appointments at the University of Zanjan, where he has built an active research programme in molecular engineering and optoelectronic materials. His professional experience spans collaborative projects with leading international groups in photovoltaics and light-emitting devices, and his work has attracted sustained citations, reflecting significant impact across energy-related materials research. His research interests include molecular design of transition-metal complexes, development of hole-transport materials, photophysical property tuning, and the creation of highly efficient electroluminescent systems. He is skilled in synthetic chemistry, spectral and electrochemical analysis, device fabrication, and structure-property correlation studies. His achievements include recognition through strong publication records, invited collaborations, and contributions to high-impact review and research articles across premier journals in chemistry and materials science. Overall, he is a dedicated scientist whose work continues to advance renewable-energy materials and molecular optoelectronic technologies, positioning him as an influential contributor to the future of functional materials research.

Profile: Googlescholar

Featured Publications

Henry Nelson Puerta-Guardo | Microbe-Host Biology and Vector Control | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Henry Nelson Puerta-Guardo | Microbe-Host Biology and Vector Control | Best Researcher Award

Universidad Autonoma de Yucatan | Mexico

Dr. Henry Puerta-Guardo is an accomplished Associate Research Professor at the Universidad Autónoma de Yucatán (UADY), Mexico, recognized for his extensive contributions to virology, viral pathogenesis, and vector-borne disease research. He completed his academic training in bacteriology at the University of San Buenaventura, followed by a master’s degree in microbiology and cellular biology from the Venezuelan Institute for Scientific Research, a PhD in infectomics and molecular pathogenesis from CINVESTAV, and postdoctoral research in viral pathogenesis at the University of California, Berkeley. His professional career spans research, teaching, and editorial roles in leading institutions and journals, where he explores the molecular mechanisms of dengue and Zika viruses, host-pathogen interactions, and vector control strategies. His primary research interests include endothelial barrier dysfunction, immune response to flavivirus infections, molecular virology, and epidemiology of arboviruses. Dr. Puerta-Guardo is skilled in cellular and molecular biology, vascular-endothelial biology, and diagnostics development. His numerous awards, such as the National Laboratory for Genomics in Biodiversity Award, the Wellcome Trust Award, and recognition from the National System for Researchers, highlight his scientific excellence. Through innovative interdisciplinary collaborations, he continues to advance global understanding of emerging infectious diseases and develop preventive strategies against arbovirus transmission in endemic regions.

Profile: Google scholar

Featured Publications

Manoj Kumar | Pathogenomics | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Manoj Kumar | Pathogenomics | Best Researcher Award

Pennsylvania State University | United States

Dr. Manoj Kumar is a bioinformatics researcher and postdoctoral scholar in the Department of Veterinary and Biomedical Sciences at Pennsylvania State University, with a strong academic foundation including doctoral and master’s degrees in bioinformatics, a bachelor’s degree in science, and additional training in artificial intelligence and machine learning. His professional career has spanned several universities and research institutions in North America, where he has developed extensive expertise in high-throughput sequencing, multi-omics integration, and pathogen genomics. He has contributed to projects in bacterial, viral, and metagenomic research, supporting diagnostics, epidemiology, and translational studies, and has collaborated with clinicians and interdisciplinary teams to deliver clinically interpretable genomic reports. His research interests center on whole-genome sequencing, antimicrobial resistance, genome-wide association studies, microbial ecology, and systems biology. He possesses strong skills in computational pipeline development, large-scale data analysis, phylogenetics, and comparative genomics, with hands-on experience across multiple sequencing platforms. Recognized through fellowships, mentorship roles, and editorial appointments, he has authored numerous peer-reviewed publications, book chapters, and conference abstracts, with his work cited widely by the global scientific community. In conclusion, Manoj Kumar exemplifies a versatile and dedicated scientist, combining advanced computational skills with biological insights to advance genomic research, strengthen diagnostic applications, and contribute meaningfully to the field of veterinary and biomedical sciences.

Profile: ORCID

Featured Publications

Muhammad Adnan Sabir Mughal | Pathobiology and Biomedical Sciences | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Muhammad Adnan Sabir Mughal | Pathobiology and Biomedical Sciences | Best Researcher Award

Muhammad Nawaz Sharif University of Agriculture | Pakistan

Dr. Muhammad Adnan Sabir Mughal is a dedicated researcher and academic from Pakistan specializing in parasitology, with a strong focus on molecular surveillance of parasites affecting humans and livestock. He holds a Doctor of Veterinary Medicine, an MPhil in Parasitology, and is pursuing a PhD in Parasitology at the University of Agriculture, Faisalabad, where his work explores the epidemiology of equine trypanosomatids in Southern Punjab. His professional experience includes teaching and research as a lecturer at leading universities such as the University of Agriculture Faisalabad, Bahauddin Zakariyya University Multan, and MNS University of Agriculture Multan, as well as editorial roles as associate editor of Biological Times and editor for Unique Scientific Publisher. His research interests extend to food- and waterborne parasites, antiparasitic potential of natural extracts, and the application of bioinformatics in novel drug design against protozoan parasites. He possesses advanced technical skills in DNA and RNA extraction, PCR, sequence and phylogenetic analysis, as well as blotting techniques, alongside clinical and diagnostic expertise in animal health. He has been recognized with bronze and silver medals for academic excellence, university merit scholarships, and a Young Leaders Award by Volunteer Force Pakistan. Dr. Mughal’s strong academic record, research contributions, and leadership highlight his potential to advance parasitology through innovative and impactful approaches.

Profile: ORCID

Featured Publications

Hongru Li | Brain Metastasis | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Hongru Li | Brain Metastasis | Best Researcher Award

Fuzhou University Affiliated Provincial Hospital | China

Dr. Hongru Li, MD/PhD, is a distinguished clinician-scientist and Chief Physician in the Department of Respiratory and Critical Care Medicine at Fujian Provincial Hospital, Fujian Medical University. With a career dedicated to advancing respiratory medicine and oncology, his expertise lies in lung cancer, metastasis mechanisms, and innovative therapeutic strategies. Over the years, he has combined clinical excellence with groundbreaking research, focusing on molecular pathways and targeted therapies. Dr. Li has published extensively in reputable journals, contributing to understanding brain and bone metastasis in non-small cell lung cancer. His leadership extends to supervising clinical innovation projects funded by national and provincial research grants. Recognized as an outstanding respiratory scholar, he has made notable contributions in translational medicine, bridging laboratory findings with patient care. His research on nanoliposomes, ceramide pathways, and genetic susceptibility in lung cancer exemplifies his commitment to improving treatment outcomes and patient survival in respiratory oncology.

Profile

ORCID

Education

Dr. Hongru Li’s academic foundation is firmly rooted in medicine and specialized respiratory science. He earned his Doctor of Medicine degree at Fujian Medical University, where he developed his core clinical knowledge and interest in pulmonary health. To deepen his expertise, he pursued postgraduate studies in respiratory medicine at Fujian Medical University, gaining hands-on exposure to advanced diagnostic and therapeutic approaches in pulmonary and critical care. His academic journey culminated with a PhD in Respiratory Medicine from Southern Medical University in Guangzhou, where he focused on molecular mechanisms of lung cancer progression and metastasis. His doctoral research provided a solid grounding in translational medicine, integrating clinical insights with cellular and molecular biology. This comprehensive educational background has enabled him to pursue a career balancing patient care with high-impact research, positioning him as a leader in respiratory medicine, oncology, and translational research with a strong focus on innovation and clinical application.

Experience

Dr. Hongru Li has accumulated extensive clinical and academic experience at Fujian Provincial Hospital, where he has advanced through progressive leadership roles in respiratory and critical care medicine. Starting as a resident doctor, he gained experience in managing complex respiratory cases, developing proficiency in critical care interventions. He then served as an attending doctor, where he refined his clinical judgment and mentored junior staff. His expertise led to his appointment as Associate Chief Physician, where he oversaw specialized clinical programs and research initiatives. Currently, as Chief Physician, Dr. Li leads the Department of Respiratory and Critical Care Medicine, managing advanced patient care, research collaborations, and clinical training. His responsibilities span from clinical decision-making to developing research projects funded by provincial and national agencies. With deep involvement in translational research, he bridges laboratory discoveries with real-world patient care, positioning him as both a skilled clinician and an innovative medical researcher.

Awards and Honors

Dr. Hongru Li has been recognized for his exceptional contributions to clinical medicine, research innovation, and academic excellence. Early in his career, he received the Excellent Graduate Award and Excellent Postgraduate Award from Fujian Medical University, reflecting his academic dedication and professional promise. His trajectory of excellence was further reinforced with the prestigious Outstanding Youth Respiratory Scholar Award for Clinical Innovation in China, acknowledging his groundbreaking research and leadership in respiratory medicine. These honors underscore his commitment to advancing lung cancer research, patient care, and translational medicine. His ability to secure competitive research funding and lead innovative studies further reflects his recognition as a trusted expert in his field. In addition, his patents and numerous peer-reviewed publications highlight the impact of his scientific contributions. These accolades collectively demonstrate not only his academic excellence but also his role as a leading physician-researcher shaping the future of respiratory and oncology medicine.

Research Focus

Dr. Hongru Li’s research centers on the molecular mechanisms driving lung cancer progression and metastasis, with particular emphasis on brain and bone metastases in non-small cell lung cancer. He explores signaling pathways, genetic susceptibility, and the role of lipids and ceramide metabolism in tumor development. His studies have investigated proteins such as livin, RPTOR, and ceramide synthase in regulating tumor proliferation, apoptosis, and metastatic spread. Through innovative approaches, including nanoliposome-based therapies, he seeks to inhibit cancer metastasis and improve treatment responses. He has also examined genetic polymorphisms and signaling cascades, such as the PI3K/AKT/mTOR and Wnt pathways, to understand cancer susceptibility and therapy resistance. His translational research aims to transform laboratory findings into clinical applications, offering new diagnostic biomarkers and therapeutic targets. Supported by national and provincial grants, his work significantly contributes to advancing precision medicine, improving survival, and developing novel treatment strategies for patients with lung cancer.

 

Publications

 

Title: KLF9 Inhibits Brain Metastasis of Non‐Small Cell Lung Cancer by Regulating Ceramide Synthase 1 Synthesis
Year: 2025

Title: Efficacy of Prophylactic Cranial Irradiation in Early to Mid-stage Small Cell Lung Cancer Patients in the Era of Magnetic Resonance Imaging
Year: 2024

Title: Development and validation of a nomogram model based on blood-based genomic mutation signature for predicting the risk of brain metastases in non-small cell lung cancer
Year: 2024

Title: Antibacterial effect of phage cocktails and phage-antibiotic synergy against pathogenic Klebsiella pneumoniae
Year: 2024

Title: Clinical application value of metagenome next-generation sequencing in pulmonary diffuse exudative lesions: a retrospective study
Year: 2024

Title: Successful treatment of severe lung cancer caused by third-generation EGFR-TKI resistance due to EGFR genotype conversion with afatinib plus anlotinib
Year: 2024

Title: RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding
Year: 2024

Conclusion

Dr. Hongru Li exemplifies the integration of clinical expertise and research innovation, dedicated to advancing respiratory and cancer medicine through groundbreaking studies, translational discoveries, and compassionate patient care.